Management of Euglycemic Diabetic Ketoacidosis

被引：0

作者：

Mathew, Daniya S. ^{[1
]}

Ng, Kimberly E. ^{[2
]}

Jacob, Elsen C. ^{[2
]}

机构：

[1] St Johns Univ, Coll Pharm & Hlth Sci, New York, NY 11439 USA

[2] St Johns Univ, Coll Pharm & Hlth Sci, Dept Clin Hlth Profess, New York, NY USA

来源：

US PHARMACIST | 2021年 / 46卷 / 11期

关键词：

INHIBITORS;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Euglycemic diabetic ketoacidosis (EDKA) is a rare, acute, life-threatening emergency that is characterized by euglycemia, metabolic acidosis, and ketoacidosis. Unlike DKA, the diagnosis of EDKA is often overlooked because of the absence of hyperglycemia. The mechanism behind EDKA involves a general state of starvation that results in ketosis while normoglycemia is maintained. EDKA may be associated with precipitating factors, including sodium-glucose cotransporter 2 inhibitors, starvation, pregnancy, alcohol use, surgery, and drug-induced intoxication. A stepwise approach is used in the management of EDKA. Pharmacists can assist the medical team in preventing EDKA and can play a role in the management of EDKA.

引用

页码：HS1 / HS6

页数：6

共 50 条

[21] Empagliflozin-Associated Euglycemic Diabetic Ketoacidosis in a Patient With Type 2 Diabetes Mellitus
Chauhan, Sukhjinder
Manov, Andrey, I
Dhillon, Gundip S.
Shah, Pinak
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (01)
[22] From Sweet to Sour: SGLT-2-Inhibitor-Induced Euglycemic Diabetic Ketoacidosis
Koceva, Andrijana
Kravos Tramsek, Nika Aleksandra
JOURNAL OF PERSONALIZED MEDICINE, 2024, 14 (07):
[23] Management of diabetic ketoacidosis in special populations
Eledrisi, Mohsen S.
Beshyah, Salem A.
Malik, Rayaz A.
DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 174
[24] A Case Report: Euglycemic Diabetic Ketoacidosis Presenting as Chest Pain in a Patient on a Low Carbohydrate Diet
Dorcely, Brenda
Nitis, Juliana
Schwartzbard, Arthur
Newman, Jonathan D.
Goldberg, Ira J.
Sum, Melissa
CURRENT DIABETES REVIEWS, 2021, 17 (02) : 243 - 246
[25] Euglycemic diabetic ketoacidosis following major vascular surgery is a new item on the differential for postoperative acidosis
Gomez-Sanchez, Clara M.
Wu, Bian X.
Gotts, Jeffrey E.
Chang, Robert W.
JOURNAL OF VASCULAR SURGERY CASES INNOVATIONS AND TECHNIQUES, 2021, 7 (04): : 778 - 780
[26] Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis
Dutta, Siddhartha
Kumar, Tarun
Singh, Surjit
Ambwani, Sneha
Charan, Jaykaran
Varthya, Shoban B.
JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2022, 11 (03) : 927 - 940
[27] Euglycemic diabetic ketoacidosis associated with the use of a sodium-glucose cotransporter-2 inhibitor
Zhang, Lydia
Tamilia, Michael
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (25) : E766 - E768
[28] Postcardiac Surgery Euglycemic Diabetic Ketoacidosis in Patients on Sodium-Glucose Cotransporter 2 Inhibitors
Auerbach, Jonathan S.
Gershengorn, Hayley B.
Aljure, Oscar D.
Lamelas, Joseph
Patel, Samira S.
Ferreira, Tanira D.
Gonzalez, Lazaro A.
Cabrera, Jorge L.
JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (06) : 956 - 963
[29] Detection of Euglycemic Diabetic Ketoacidosis During Thoracic Surgery 75 Hours After Empagliflozin Discontinuation
Nishida, Ai
Ogawa, Osamu
Takizawa, Hiroki
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (10)
[30] Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review
Sampani, Erasmia
Sarafidis, Pantelis
Dimitriadis, Chrysostomos
Kasimatis, Efstratios
Daikidou, Dimitra
Bantis, Konstantinos
Papanikolaou, Alexios
Papagianni, Aikaterini
BMC NEPHROLOGY, 2020, 21 (01)

← 1 2 3 4 5 →